However, endometrial cancer patients with downregulated PTEN and DHX30 tended to have worse prognosis, compared to patients where this is not the case (Appendix Fig S19B); this suggests that not all the SL interactions identified by CLIP are supported by the survival analyses in the patient cohorts. Here, PTEN is linked to endometrial cancer.